info@connexo.io

;
thumb

Services

We are together with you every step of the way – in ensuring usability and your compliance is always our top priority.

Key Services
GxP Risk Assessment & Benchmarking
Support of inspection readiness and post audit response preparation
Life Science Software Validation & Implementation
Development & Implementation of Quality Systems
Training & Coaching
Support in Remediation plans and CAPAs
Due Diligence in M & A
Performing Internal Inspections to Ensure All Time Readiness and Compliance
Building Culture of Quality
EQMS (EDMS)
Manufacturing Execution System (MES)
Electronic Batch Manufacturing Record(EBMR)
Distributed Control Systems (DCS)
PLCs & SCADA
Environmental Monitoring Systems
Electronic Log Books
Access Control Systems
Learning Management Systems (LMS)
Warehouse Management System
Track and Trace
Barcode Scanners & Barcode Labels
GxP Audit Remediation
CSV & CSA for all GxP Systems
GxP Training
GxP Risk Assessment & Gap Analysis
Version Upgrades and Patch Management
AI Based FDA Observation Management
Data Analytics & Visualisation in line with USFDA Process Metrics Guide
Risk Based User Access Management for GxP Systems

Training/Education

We are together with you every step of the way – in ensuring usability and your compliance is always our top priority.

Fundamental of Computerized System Validation

A software application or a computerized system needs to be planned and implemented. Therefore, the use of a system life cycle is important as it provides a plan to use as a basis for the implementation or building of a computerized system

Read More

SOPs and Validation Deliverables

Validation Master Plan. CSV SOPs. How to write appropriate specification (URS), Risk Assessment and other GAMP Methodology validation deliverables.  Vendor Assessment. Data backup and restoration Verification  Audit trail review

Read More

21 CFR Part 11 and (Annex 11 – 1)

Evaluation and Key requirements of 21 CFR part 11. Evaluation and Key requirements of Annex 11. Relationship between Part 11 and Annex 11.

Read More

21 CFR Part 11 and (Annex 11 – 2)

Learning form 483: Warning letter are key wealth destroyer for pharma company market capital and reputation. Inspection Readiness.

Read More

Data integrity

Understanding of Data Integrity Fundamentals. Data Integrity Guidance from USFDA/MHRA/EMA/WHO/PCS: What are the similarities and differences between the guidance? Understand with examples difference between improper practice and data integrity.

Read More
; ;